Is Quest Diagnostics Stock Outperforming the S&P 500?

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and services in the United States and internationally. It operates through two business groups - Diagnostic Information Services and Diagnostic Solutions, offering routine and specialized clinical testing, pathology services, and health IT solutions.

Companies valued at $10 billion or more are generally considered “large-cap” stocks, and Quest Diagnostics fits this criterion perfectly. Headquartered in Secaucus, New Jersey, Quest focuses on accelerating growth through strategic initiatives and driving operational excellence to enhance efficiency and customer value.